We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Apply for a dermatological product to be considered by the Advisory Committee on Borderline Substances (ACBS).
A retrospective hospital-based, cross-sectional study carried out between 2016 to 2017
Information and advice on submitting a dermatological product to the Advisory Committee for Borderline Substances (ACBS).
Report of Isotretinoin Implementation Advisory Expert Working Group regarding recommendations to strengthen the safe use of isotretinoin, the acne medicine commonly known by brand names Roaccutane and Reticutan.
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
The review of the safety of isotretinoin has concluded.
Guidance for primary care on taking samples for diagnosing and treating fungal skin and nail infections; for consultation and adaptation.
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
Guidance and support on coronavirus (COVID-19) in Scotland.
This document details the service standards of the Veterinary Medicines Directorate (VMD)
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the Department of Health and Social Care .
Tools and models to support the development of the public health contribution of nurses, midwives and allied health professionals.
Information on the reporting, investigation and management of acute flaccid paralysis (AFP) and acute flaccid myelitis (AFM).
For medical professionals, the Medical Reserves offer an exciting opportunity to do more with your professional skills. Follow the links below to find out more.
Information on COVID-19, including guidance on the assessment and management of suspected UK cases.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.